UCSF 17th Annual Osteoporosis New Insights in Research, Diagnosis, and Clinical Care 2020

Overview:

This single day virtual course features an expert faculty that will discuss the epidemiology, pathophysiology, diagnosis, and treatment of osteoporosis. Specific topics will include the cell biology of osteoporosis, bone biomechanics, endocrine and nutrition aspects of osteoporosis, and advances in skeletal imaging. The course will also critically review current treatment options and preview new treatments.

TARGET AUDIENCE
The course will provide an update on current recommendations about screening and treatment of osteoporosis for physicians and other clinicians working with osteoporosis patients. It will also benefit researchers, technologists and pharmaceutical or device company professionals who would find additional scientific background in the disease helpful. This year the conference will focus on the latest clinical updates and controversies about diagnosis and pharmacologic therapies. No prior clinical or scientific training in osteoporosis is required.

Objectives:

An attendee completing this course will be able to:

• Provide appropriate pharmacological treatment for osteoporosis, including the use of new therapies;
• Evaluate the benefits and risks of continuing long-term antiresorptive and anabolic osteoporosis therapy and determine optimal treatment duration;
• Evaluate in whom and when a drug holiday would be appropriate for patients on bisphosphonates;
• Choose appropriate follow-on therapy for the anabolic therapies teriparatide, abaloparatide and romosozumab;
• Understand bone health issues in transgender patients.